Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene
Open Access
- 13 August 2001
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 194 (4), 393-406
- https://doi.org/10.1084/jem.194.4.393
Abstract
MHC class II (MHCII) molecules play a pivotal role in the induction and regulation of immune responses. The transcriptional coactivator class II transactivator (CIITA) controls MHCII expression. The CIITA gene is regulated by three independent promoters (pI, pIII, pIV). We have generated pIV knockout mice. These mice exhibit selective abrogation of interferon (IFN)-γ–induced MHCII expression on a wide variety of non-bone marrow–derived cells, including endothelia, epithelia, astrocytes, and fibroblasts. Constitutive MHCII expression on cortical thymic epithelial cells, and thus positive selection of CD4+ T cells, is also abolished. In contrast, constitutive and inducible MHCII expression is unaffected on professional antigen-presenting cells, including B cells, dendritic cells, and IFN-γ–activated cells of the macrophage lineage. pIV−/− mice have thus allowed precise definition of CIITA pIV usage in vivo. Moreover, they represent a unique animal model for studying the significance and contribution of MHCII-mediated antigen presentation by nonprofessional antigen-presenting cells in health and disease.Keywords
This publication has 71 references indexed in Scilit:
- Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expressionImmunological Reviews, 2000
- Major histocompatibility complex class II deficiency: a clinical reviewBlood Reviews, 1996
- Conditional gene targeting.JCI Insight, 1996
- Acre-transgenic mouse strain for the ubiquitous deletion ofloxP-flanked gene segments including deletion in germ cellsNucleic Acids Research, 1995
- Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcomeThe Journal of Pediatrics, 1993
- Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)Cell, 1993
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- The Complex Role of Epithelial Cell MHC Class II Antigen Expression in Autoimmune Endocrine DiseaseAutoimmunity, 1990
- MHC class II expression by the gut epitheliumImmunology Today, 1988
- Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.The Journal of Experimental Medicine, 1985